Monthly Archives: July 2020

Gilead’s antiviral COVID-19 gets conditional EU approval

The European Commission (EC) has granted conditional approval for the use of remdesivir of the antiviral drug Gilead (GILD) in critically ill patients with COVID-19, making it the first drug authorized by the body for treatment against the virus. Remdesivir is an antiviral medication developed for use against Ebola. It …

Read More »